A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon
Talitha I. Verhoef(Apple (Israel)), Anke H. Maitland‐van der Zee(Utrecht University), Vangelis G. Manolopoulos(Laboratory of Molecular Genetics), Dimitrios Tziakas, M.G.H. Remkes, Frits R. Rosendaal(Leiden University Medical Center), Ken Redekop(Erasmus University Rotterdam), Stavros Konstantinides(Johannes Gutenberg University Mainz), Vana Kolovou(Onassis Cardiac Surgery Center), Genovefa Kolovou(Onassis Cardiac Surgery Center), F.J.M. van der Meer(Leiden University Medical Center), Rianne MF van Schie(Utrecht University), Efstratios Maltezos(Democritus University of Thrace), Anna Tavridou(Laboratory of Molecular Genetics), Anthonius de Boer(Utrecht University), Saskia le Cessie(Leiden University Medical Center), Mia Wadelius(Uppsala University), Rita Barallon, Georgia Ragia(Laboratory of Molecular Genetics)
Cited by 226
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
|European Respiratory Journal|2019|1.6k
Incidence and mortality of venous thrombosis: a population‐based study
|Journal of Thrombosis and Haemostasis|2007|1.4k